Question 1

Does Centiva Capital own ABCL stock?

Accepted Answer

No. Centiva Capital exited its ABCL (AbCellera Biologics) position in Q2 2025. Its Q1 2025 13F listed 46,621 shares worth $103,965.

Question 2

How many shares of ABCL does Centiva Capital own?

Accepted Answer

None since Q2 2025, when Centiva Capital exited the position. Its Q1 2025 13F listed 46,621 shares worth $103,965.

Question 3

What is Centiva Capital's ABCL position worth?

Accepted Answer

Centiva Capital's ABCL position was worth $103,965 in its Q1 2025 13F, before the exit in Q2 2025.

Question 4

Is Centiva Capital buying or selling ABCL?

Accepted Answer

In Q2 2025, Centiva Capital exited its entire ABCL position.

Question 5

When did Centiva Capital first buy ABCL?

Accepted Answer

Centiva Capital first reported ABCL in its Q1 2021 13F and listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$3.43	0
2025-Q1	Decreased	46,621	-25.9%	$103,965	0.0%	$2.23	0
2024-Q4	New	62,899	—	$184,294	0.0%	$2.93	31